Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Procaps Group, S.A.

Procaps Group, S.A. (PROCW) Stock Overview

Explore Procaps Group, S.A.’s financial performance, market position, analyst ratings, and future outlook.

PROCW●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.02
$0.005(33.79%)
U.S. Market is Open · 13:55

Procaps Group, S.A. (PROCW)

Meyka AI Score

Z

Key Financials

Market Cap2M
P/E Ratio0.05
EPS (TTM)N/A
ROE-2.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

PROCW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Procaps Group, S.A. (NASDAQ: PROCW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Procaps Group, S.A.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PROCW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Procaps Group, S.A.'s NASDAQ-traded stock include a P/E ratio of 0.05 and a market capitalization of 2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PROCW on the NASDAQ.

Price Performance (NASDAQ: PROCW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
-92.21%
5-Year Change
-98.20%
All-Time (Max) Change
-98.20%

Contact Information

http://www.procapsgroup.com
356 7995 6138
9 rue de Bitbourg, Luxembourg City, NaN, 1273

Company Facts

55,000 Employees
IPO DateSep 30, 2021
CountryLU

Frequently Asked Questions